PortfoliosLab logo

Adamis Pharmaceuticals Corporation (ADMP)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS00547W2089
CUSIP00547W208
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$0.45
Year Range$0.34 - $1.23
EMA (50)$0.45
EMA (200)$0.67
Average Volume$646.11K
Market Capitalization$68.07M

ADMPShare Price Chart


Chart placeholderClick Calculate to get results

ADMPPerformance

The chart shows the growth of $10,000 invested in Adamis Pharmaceuticals Corporation on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $827 for a total return of roughly -91.73%. All prices are adjusted for splits and dividends.


ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

ADMPReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-2.17%-6.21%
YTD-26.23%-18.17%
6M-29.69%-17.47%
1Y-63.41%-8.89%
5Y-38.27%10.04%
10Y-28.19%11.39%

ADMPMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ADMPSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adamis Pharmaceuticals Corporation Sharpe ratio is -0.88. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

ADMPDividend History


Adamis Pharmaceuticals Corporation doesn't pay dividends

ADMPDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

ADMPWorst Drawdowns

The table below shows the maximum drawdowns of the Adamis Pharmaceuticals Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adamis Pharmaceuticals Corporation is 98.17%, recorded on Mar 19, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.17%Nov 9, 20121851Mar 19, 2020
-70.59%Jan 14, 2010533Feb 27, 201241Apr 25, 2012574
-37.66%Jun 20, 201258Sep 11, 201228Oct 19, 201286
-32.65%May 2, 20127May 10, 201216Jun 4, 201223
-8.45%Apr 30, 20121Apr 30, 20121May 1, 20122
-7.89%Jun 6, 20122Jun 7, 20127Jun 18, 20129
-5%Oct 26, 20121Oct 26, 20123Nov 2, 20124
-4.69%Jan 5, 20101Jan 5, 20101Jan 6, 20102
-0.96%Nov 5, 20121Nov 5, 20121Nov 6, 20122

ADMPVolatility Chart

Current Adamis Pharmaceuticals Corporation volatility is 71.90%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

Portfolios with Adamis Pharmaceuticals Corporation


Loading data...